S. Branford, Z. Rudzki, S. Walsh, et al. Detection of BCR-ABL mutations in patients with CML treated with imatinib is virtually always accompanied by clinical resistance, and muta-tions in the ATP phosphate-binding loop (P-loop) are associated with a poor prognosis. Blood, 2003, 102: 276-283.

相关文章:
在线客服:
对外合作:
联系方式:400-6379-560
投诉建议:feedback@hanspub.org
客服号

人工客服,优惠资讯,稿件咨询
公众号

科技前沿与学术知识分享